Ceruloplasmin Level in Women with Breast Disease Preliminary Results

Authors

  • Özoür Özyilkan Institute of Oncology and Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara, Turkey
  • Eşmen Baltali Institute of Oncology and Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara, Turkey
  • Esin Özyilkan Institute of Oncology and Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara, Turkey
  • Gülten Tekuzman Institute of Oncology and Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara, Turkey
  • Ayşe Kars Institute of Oncology and Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara, Turkey
  • Dinçer Firat Institute of Oncology and Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara, Turkey

DOI:

https://doi.org/10.3109/02841869209089716

Abstract

The average ceruloplasmin levels of 29 patients with active breast cancer and 22 patients in remission were 824 ± 61 mg/l and 630 ± 18 mg/l respectively. The average ceruloplasmin level of 17 patients with benign breast diseases was 555 ± 29 mg/l and of 18 healthy women in a control group 584 ± 17 mg/l. Breast cancer patients not in remission had ceruloplasmin levels which were significantly increased when compared to the other 3 groups. The CA 15-3 levels and ceruloplasmin levels were positively correlated. We propose that ceruloplasmin may be used as a tumour marker in the follow-up of patients with breast cancer.

Downloads

Download data is not yet available.

Downloads

Published

1992-01-01

How to Cite

Özyilkan, Özoür, Baltali, E., Özyilkan, E., Tekuzman, G., Kars, A., & Firat, D. (1992). Ceruloplasmin Level in Women with Breast Disease Preliminary Results. Acta Oncologica, 31(8), 843–846. https://doi.org/10.3109/02841869209089716

Issue

Vol. 31 No. 8 (1992): Acta Oncologica

Section

Articles